Insider · CIK 0001796908
Marvin Slosman
Files at BCDA (BioCardia, Inc.), NSPR (InspireMD, Inc.). First filing Aug 1, 2025, latest May 13, 2026.
In brief
Marvin Slosman files SEC Form 4 as CEO, president and director at NSPR (InspireMD, Inc.), and also at BCDA (BioCardia, Inc.). Since Aug 1, 2025, Marvin Slosman has reported 2 open-market buys worth $50k and 0 open-market sells worth $0, the latest filed on May 13, 2026.
A track record needs three past buys with six months of prices behind them; Marvin Slosman has 1, so none is measured yet.
The newest scored trade: bought $25k of NSPR on May 12, 2026, filed May 13, 2026, scored 58 (moderate). In the last 12 months: 1 buy worth $25k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NSPR: InspireMD, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | InspireMD, Inc. | $25k 21,000 shares | +1% | +9% from low-57% from high | |
| 35Weak | InspireMD, Inc. | $25k 10,330 shares | +0% | - |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +8,000 | $0.00 | $0 | 20,000 | Jul 7, 2026 |
| May 12, 2026 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +21,000 | $1.20 | $25k | 3,556,658 | May 13, 2026 |
| Jan 14, 2026 | NSPR InspireMD, Inc. | AGrant or award Restricted Stock Units | +1,114,792 | $0.00 | $0 | 3,535,658 | Jan 16, 2026 |
| Dec 8, 2025 | BCDA BioCardia, Inc. | AGrant or award Stock Option (right to buy)derivative | +12,000 | $0.00 | $0 | 12,000 | Dec 10, 2025 |
| Jul 30, 2025 | NSPR InspireMD, Inc. | POpen-market purchase Common Stock | +10,330 | $2.42 | $25k | 2,420,866 | Aug 1, 2025 |
| Jan 7, 2025 | NSPR InspireMD, Inc. | AGrant or award Restricted Stock Units | +558,417 | $0.00 | $0 | 2,410,536 | Jan 10, 2025 |
| Jan 7, 2025 | NSPR InspireMD, Inc. | AGrant or award Options to purchase common stock (right to buy)derivative | +254,985 | $0.00 | $0 | 937,796 | Jan 10, 2025 |
Questions about Marvin Slosman
Answered from the filings on this page, as of the latest one.
Is Marvin Slosman buying or selling?
In the last 12 months Marvin Slosman reported 1 open-market buy worth $25k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $25k of NSPR on May 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Marvin Slosman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marvin Slosman has 1.
Where does Marvin Slosman file Form 4?
Marvin Slosman has filed Form 4 at NSPR (InspireMD, Inc.) as CEO and President; BCDA (BioCardia, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.